The New South Wales government’s proposed changes to drug driving laws, targeting medical cannabis users, have raised concerns about potential increases in Compulsory Third Party (CTP) insurance costs and road safety. The legislation, introduced by Premier Chris Minns’ administration, is poised for a final vote in the Upper House, with Labor holding sufficient numbers for passage.
The reforms would allow registered medical cannabis patients to drive with THC levels exceeding the current threshold of 50 nanograms per litre without facing immediate penalties. Instead, these drivers would receive two formal warnings under a new three-strikes warning system before any legal action is taken. Transport Minister John Graham acknowledged the government has not conducted any cost modelling to assess how these changes might affect CTP insurance premiums, leaving uncertainty about the financial impact on motorists.
Opposition figures and medical professionals have voiced strong opposition to the legislation. Liberal Transport spokeswoman Natalie Ward criticized the lack of analysis on potential insurance cost increases, questioning who would bear the burden if insurers raise premiums. “The Premier’s three-strikes policy for medicinal cannabis users getting caught drug driving won’t make our roads safer — who is going to foot the bill if insurers jack up their prices?” Ward said, urging Premier Minns to guarantee that insurance companies would not raise costs as a result of the reforms.
The Insurance Council of Australia (ICA) has indicated that any impact on premiums cannot be determined yet, stating that insurers will continue to evaluate emerging data and evidence before making pricing decisions.
In addition to the legislative changes, the government plans to incorporate a medical cannabis registration system into the state’s digital driver’s licences. Drivers who opt into the drug-driving warning scheme will have a discreet notation on their digital licence reflecting their prescription status. This information will be stored in the Transport for NSW “DRIVES” database, with access restricted to authorized personnel based on necessity, according to Roads Minister Jenny Aitchison, who emphasized measures to protect patient privacy and safety.
Despite these safeguards, medical professionals remain concerned. Dr. Geoff Healy, Director of Trauma Services at Royal North Shore Hospital, was among several doctors who sent a letter to Premier Minns expressing fears that the reforms could increase risks to the broader public. “I really fear for our general population that they’re going to be put at increased risk,” Dr. Healy said.
The legislation has drawn a clear divide between the government’s approach to accommodating medicinal cannabis users and the opposition and some health experts’ concerns about the potential consequences for road safety and insurance costs. The final vote in the Upper House remains a crucial step in determining how these changes will be implemented and what effects they may have.